This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2004
Title: Marcel Morvan: Innovator in Receptor Antagonists
Introduction
Marcel Morvan is a notable inventor based in St Grégoire, France. He has made significant contributions to the field of pharmacology, particularly in the development of receptor antagonists. His work has implications for various therapeutic applications.
Latest Patents
Marcel Morvan holds a patent for "Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists." This patent represents his innovative approach to targeting specific receptors, which could lead to advancements in treatment options.
Career Highlights
Throughout his career, Morvan has focused on the intersection of chemistry and medicine. His research has led to the development of compounds that may play a crucial role in managing various health conditions. He has been recognized for his contributions to the scientific community.
Collaborations
Marcel has worked alongside esteemed colleagues such as Carlo Farina and Giuseppe Giardina. Their collaborative efforts have furthered research in receptor antagonism and enhanced the potential for new therapeutic strategies.
Conclusion
Marcel Morvan's work exemplifies the spirit of innovation in the field of pharmacology. His patent and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile